The Head of Patient Advocacy and Professional Societies Engagement - Oncology leads the global strategy for building, managing, and sustaining authentic, high-impact relationships with cancer patient advocacy organizations (PAOs), professional oncology societies, and key policy stakeholders.

This leadership role will embed a patient-centric mindset across the Global Oncology Medical Affairs enterprise. will ensure the patient voice shapes clinical pathways across our robust portfolio of Antibody-Drug Conjugates (ADCs), T-Cell Engagers (TCEs), and targeted small molecules.  Will manage, mentor, and develop a high-performing global team of 4 direct reports focused entirely on the hematology and solid tumor landscape.

Position will be based from an AbbVie major R&D site and follow a hybrid model of 3 days/week on-site. Locations include Mettawa, IL (headquarters), Florham Park, NJ, Waltham, MA, San Francisco, CA, and Irvine, CA.

Key Responsibilities

• Global Strategy & Pipeline Integration: Design and execute the multi-year global engagement strategy for oncology PAOs aligned with AbbVie’s core therapeutic focus areas, spanning Hematologic Malignancies (CLL, AML, DLBCL, Multiple Myeloma) and Solid Tumors (NSCLC, SCLC, Ovarian Cancer, Colorectal Cancer).
• Modality-Specific Advocacy: Develop specialized, tailored patient engagement frameworks for next-generation modalities, capturing patient and caregiver insights unique to Topoisomerase I inhibitor (Top1i)–based ADCs and immune-based pipelines.
• Team Leadership & Development: Lead, mentor, and scale a team of 4 direct reports, fostering a culture of compliance, clinical fluency, and cross-functional collaboration in the complex global oncology space.
• Clinical Trial Co-Creation: Partner with clinical development to leverage patient organization insights to optimize trial designs, decentralized trial models, and patient-reported outcomes (PROs) for late-stage and registrational pipeline assets.
• Professional Oncology Alliances: Cultivate strategic partnerships with primary global professional organizations (such as ASCO, ESMO, ASH, WCLC, and SGO) to advance scientific exchange, consensus-building, and independent medical educational grants.
• Launch Readiness & Access Advocacy: Work cross-functionally to bridge medical strategy with health equity, supporting access and addressing policy and reimbursement barriers ahead of major regulatory approvals and label expansions.
• Compliance & Transparency: Ensure all team interactions adhere to regional legal/compliance codes (such as PhRMA, EFPIA, IFPMA) and navigate rigorous Fair Market Value (FMV) standards for multi-stakeholder healthcare collaborations.